PCI Biotech Holding ASA (PCIB):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH105495FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

PCI Biotech Holding ASA (PCI Biotech) is a biotechnology company. It commercializes a patented photochemical drug delivery technology for use in therapeutic treatment. PCI’s lead product Amphinex induces photochemical internalization (PCI) of chemotherapeutic agents in localized cancers. It is used for treatment of bile duct, head and neck cancer. PCI can be used in the areas of gene therapy, protein therapy, oligonucleotide therapy, chemotherapy and nanomedicine. The company is a subsidiary of PCI Biotech AS. PCI Biotech is headquartered in Lysaker, Norway.

In January 2014, PCI Biotech was awarded NOK12.5m in a BIA grant from The Research Council of Norway to the project “Development of photochemical internalization to enhance the effect of therapeutic and prophylactic vaccines”.

PCI Biotech Holding ASA Key Recent Developments

May 15, 2013: PCI Biotech Reports Q1 2013 Results
Mar 11, 2013: PCI Biotech Reports 2012 Results

This comprehensive SWOT profile of PCI Biotech Holding ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PCI Biotech Holding ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

PCI Biotech Holding ASA – Key Information
PCI Biotech Holding ASA – Overview
PCI Biotech Holding ASA – Key Employees
PCI Biotech Holding ASA – Key Employee Biographies
PCI Biotech Holding ASA – Key Operational Heads
PCI Biotech Holding ASA – Major Products and Services
PCI Biotech Holding ASA – History
PCI Biotech Holding ASA – Company Statement
PCI Biotech Holding ASA – Locations And Subsidiaries
PCI Biotech Holding ASA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

PCI Biotech Holding ASA – Business Description
PCI Biotech Holding ASA – Corporate Strategy
PCI Biotech Holding ASA – SWOT Analysis
SWOT Analysis – Overview
PCI Biotech Holding ASA – Strengths
PCI Biotech Holding ASA – Weaknesses
PCI Biotech Holding ASA – Opportunities
PCI Biotech Holding ASA – Threats
PCI Biotech Holding ASA – Key Competitors

Section 3 – Company Financial Performance Charts

PCI Biotech Holding ASA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

PCI Biotech Holding ASA, Key Information
PCI Biotech Holding ASA, Key Ratios
PCI Biotech Holding ASA, Share Data
PCI Biotech Holding ASA, Major Products and Services
PCI Biotech Holding ASA, History
PCI Biotech Holding ASA, Key Employees
PCI Biotech Holding ASA, Key Employee Biographies
PCI Biotech Holding ASA, Key Operational Heads
PCI Biotech Holding ASA, Other Locations
PCI Biotech Holding ASA, Subsidiaries
PCI Biotech Holding ASA, Key Manufacturing facilities
PCI Biotech Holding ASA, Key Competitors
PCI Biotech Holding ASA, SWOT Analysis
PCI Biotech Holding ASA, Ratios based on current share price
PCI Biotech Holding ASA, Annual Ratios
PCI Biotech Holding ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

PCI Biotech Holding ASA, Performance Chart
PCI Biotech Holding ASA, Ratio Charts

★海外企業調査レポート[PCI Biotech Holding ASA (PCIB):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China International Water & Electric Corp.:企業の戦略的SWOT分析
    China International Water & Electric Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Carillion plc:企業のM&A・提携・投資分析
    Carillion plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carillion plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Intrum Justitia AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intrum Justitia AB Mergers and …
  • Petronet LNG Limited (PETRONET):企業のM&A・提携動向(石油・ガス分野)
    Summary Petronet LNG Limited (Petronet) is a midstream energy company. It was formed as a joint venture by the Government of India to import liquefied natural gas (LNG) and set up LNG terminals in the country. Its major promoters include GAIL (India) Ltd, Oil & Natural Gas Corporation Ltd (ONGC), In …
  • T.Spiritual World Limited (532444):企業概要、財務及び戦略的SWOT分析
    Summary T.Spiritual World Limited (T.Spiritual) is a healthcare service provider. The company provides healthcare and wellness products. Its business units include software service, wellness store, wonder yoga studio and wellness clinic. T.Spiritual’s software services segment offers software soluti …
  • Gateway Financial Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gateway Financial Holdings, Inc …
  • Exosome Diagnostics, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Exosome Diagnostics, Inc. (Exosome Diagnostics) is a medical device company that designs, develops, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. The company offers various liquid biopsy tests kits for BioFluid RNA purificat …
  • Andritz AG (ANDR)(エネルギー分野):企業M&A動向
    Summary Andritz AG (Andritz) conducts the development of industrial process solutions for a broad set of industries. It supplies customized plants, systems, and services to pulp and paper, metal industries, and solid and liquid separation in industrial and municipal sectors. It also offer these serv …
  • ImageONE Co., Ltd. (2667):企業概要、財務及び戦略的SWOT分析
    Summary ImageONE Co., Ltd. (ImageOne) is an information technology service provider. The company provides digital image information products and services. It offers medical information and integration systems, medical image viewers, iPad/iPhone, server systems, image viewer systems, ultrasound syste …
  • Whole Foods Market, Inc.:企業の戦略・SWOT・財務分析
    SummaryWhole Foods Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Interfor Corporation:企業の戦略・SWOT・財務分析
    SummaryInterfor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Nuron Biotech, Inc.(製薬・医療分野):企業M&A動向
    Summary Nuron Biotech, Inc., (Nuron Biotech) is a biotech company. The company develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. It offers drug candidate, NU100 (RELONSIV), a human interferon beta-1b being developed as a new molecula …
  • Clariant Ltd.:企業の戦略・SWOT・財務分析
    Clariant Ltd. - Strategy, SWOT and Corporate Finance Report Summary Clariant Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fifth Third Bank:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fifth Third Bank Mergers and Ac …
  • Telekom Austria AG:企業のM&A・提携・投資分析
    Telekom Austria AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Telekom Austria AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Frigo Pak Gida Maddeleri Sanayi ve Tic.:企業の戦略・SWOT・財務分析
    SummaryFrigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Neurocrine Biosciences, Inc.:製品開発パイプライン動向2015
    Neurocrine Biosciences, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Neurocrine Biosciences, Inc. - Product Pipeline Review - 2015’, provides an overview of the Neurocrine Biosciences, Inc.’s pharmaceutical research and development focus. This report provides comprehensive …
  • Empired Ltd (EPD):企業概要、財務及び戦略的SWOT分析
    Summary Empired Ltd (Empired) is an information technology service provider. The company provides enterprise IT services and solutions to government and private sectors. Its infrastructure services include managed services, project services and cloud and service integration. Empired offers applicati …
  • Enel Green Power S.p.A. (EGPW):企業のM&A・提携動向(発電分野)
    Summary Enel Green Power S.p.A. (Enel Green Power) a subsidiary of Enel SpA, is an energy company that develops and manages renewable energy generation assets. Its generation portfolio includes wind, hydro, geothermal, solar, and biomass plants. The company also has interests in under construction a …
  • Luminus Devices, Inc.:企業のM&A・提携動向(発電分野)
    Summary Luminus Devices, Inc. (Luminus Devices), a subsidiary of Lightera Corporation is a lighting product manufacturer that develops and manufactures solid state light sources for illumination applications. The company offers products, which include COB arrays, mid power LEDs, high brightness, whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆